Find News

Filter articles

Applied Filters

Showing 161 to 170 of 1072 results

Collegium settles patent dispute with Teva

Israel, US30-09-2020Sarah Morgan

Massachusetts-based Collegium Pharmaceutical has reached a settlement agreement with Teva, resolving its patent litigation over pain medication.

Janssen sues Mylan to block generic of schizophrenia drug

US29-09-2020Muireann Bolger

A Johnson & Johnson company, Janssen Pharmaceuticals, is seeking a court order blocking Mylan from making copies of its schizophrenia treatment, Invega Trinza, until its patent expires in 2036.

Bausch Health settles with Sun Pharma

Canada, India, US23-09-2020Sarah Morgan

Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.

BMS and Dr Reddy’s settle Revlimid suit with generics licence

US22-09-2020Rory O'Neill

Bristol Myers Squibb and Celgene have settled their patent litigation with Dr Reddy’s over a generic version of cancer drug Revlimid.

Gilead accused of illegally paying to delay HIV drug competition

US22-09-2020Muireann Bolger

Biopharmaceutical company Gilead is being sued for allegedly scheming to prevent a generic rival from releasing a competing version of its HIV drug Truvada, according to a class action lawsuit filed by investors in the drug manufacturer.

Biogen loses another battle over MS drug patent

US21-09-2020Muireann Bolger

In a blow for biotechnology company, Biogen, a US federal judge has ruled that its lone surviving patent on multiple-sclerosis drug Tecfidera should remain invalid because the matter had already been resolved by another court.

EPO revokes Copaxone patent, clears path for Mylan

EU17-09-2020Sarah Morgan

The European Patent Office has invalidated and revoked a patent related to Teva’s multiple sclerosis drug Copaxone, in a win for Mylan.

Orexo sues Sun Pharma over opioid dependence generic

Sweden, US16-09-2020Sarah Morgan

Swedish pharmaceutical company Orexo has taken India-based Sun Pharmaceutical to court in the US, over its plans to launch a generic version of Orexo’s opioid dependence treatment.

Judge gives initial approval to Actavis $20m antitrust deal

US15-09-2020Sarah Morgan

A Massachusetts judge has provided her preliminary approval to a $19.9 million settlement in a class action antitrust suit brought against pharmaceutical company Actavis. 

Ruling opens door for Noven’s oestrogen patch generics

US10-09-2020Sarah Morgan

In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Showing 161 to 170 of 1072 results